Literature DB >> 23043708

Sputum microRNA profiling: a novel approach for the early detection of non-small cell lung cancer.

Wilson H Roa1, Julian O Kim, Rene Razzak, Hongfei Du, Linghong Guo, Ravinder Singh, Sayf Gazala, Sunita Ghosh, Eric Wong, Anil A Joy, James Z Xing, Eric L Bedard.   

Abstract

PURPOSE: MicroRNAs (miRNAs) post-transcriptionally regulate hundreds of gene targets involved in tumorigenesis thereby controlling vital biological processes, including cellular proliferation, differentiation and apoptosis. MiRNA profiling is an emerging tool for the potential early detection of a variety of malignancies. This study was conducyed to assess the feasibility and methodological robustness of quantifying sputum miRNAs, employing quantitative real-time polymerase chain reaction (RT-qPCR) and cluster analysis on an optimized miRNA profile as a novel approach for the early detection of non-small cell lung cancer (NSCLC).
METHODS: The relative expressions of 11 miRNAs in sputum (miR-21, miR-145, miR-155, miR-205, miR-210, miR-92, miR-17-5p, miR-143, miR-182, miR-372, and let-7a) in addition to U6 were retrospectively assessed in four NSCLC-positive and four negative controls. Subsequently, a set of five miRNAs (miR-21, miR-143, miR-155, miR-210, miR-372) was selected because of degree of relatedness observed in the cluster analysis and tested in the same sputum sample set. The five optimized miRNAs accurately clustered these eight retrospective patients into NSCLC positive cases and negative controls. The five miRNA panel was then prospectively quantified in the sputum of 30 study patients (24 NSCLC cases and six negative controls) in a double-blind fashion to validate a five miRNA panel using hierarchical cluster analysis.
RESULTS: The optimized five miRNA panel detected NSCLC (83.3% sensitivity and 100% specificity) in 30 prospectively accrued study patients.
CONCLUSION: Sputum miRNA profiling using cluster analysis is a promising approach for the early detection of non-small cell lung cancer. Further investigation using this approach is warranted.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23043708     DOI: 10.25011/cim.v35i5.18700

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  32 in total

1.  MicroRNAs level as an initial screening method for early-stage lung cancer: a bivariate diagnostic random-effects meta-analysis.

Authors:  Wen-Jie He; Wen-Hui Li; Bo Jiang; Yu-Feng Wang; Yao-Xiong Xia; Li Wang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  MicroRNAs as novel biomarkers in the diagnosis of non-small cell lung cancer: a meta-analysis based on 20 studies.

Authors:  Ling Chen; Hai Jin
Journal:  Tumour Biol       Date:  2014-06-12

3.  Air toxics and epigenetic effects: ozone altered microRNAs in the sputum of human subjects.

Authors:  Rebecca C Fry; Julia E Rager; Rebecca Bauer; Elizabeth Sebastian; David B Peden; Ilona Jaspers; Neil E Alexis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-04-25       Impact factor: 5.464

4.  MicroRNA expression profiling of sputum for the detection of early and locally advanced non-small-cell lung cancer: a prospective case-control study.

Authors:  R Razzak; E L R Bédard; J O Kim; S Gazala; L Guo; S Ghosh; A Joy; T Nijjar; E Wong; W H Roa
Journal:  Curr Oncol       Date:  2016-04-13       Impact factor: 3.677

Review 5.  MicroRNAs in lung cancer.

Authors:  Pooja Joshi; Justin Middleton; Young-Jun Jeon; Michela Garofalo
Journal:  World J Methodol       Date:  2014-06-26

6.  Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules.

Authors:  Lingxiao Xing; Jian Su; Maria A Guarnera; Howard Zhang; Ling Cai; Rixin Zhou; Sanford A Stass; Feng Jiang
Journal:  Clin Cancer Res       Date:  2015-01-15       Impact factor: 12.531

Review 7.  MicroRNAs as ideal biomarkers for the diagnosis of lung cancer.

Authors:  Zhiqiang Guo; Chuncheng Zhao; Zheng Wang
Journal:  Tumour Biol       Date:  2014-07-23

8.  MicroRNA-133a downregulated EGFR expression in human non-small cell lung cancer cells via AKT/ERK signaling.

Authors:  Nannan Guo; Yingnan Zhao; Wen Zhang; Shaojun Li; Shanshan Li; Jianqi Yu
Journal:  Oncol Lett       Date:  2018-09-05       Impact factor: 2.967

Review 9.  MicroRNAs as lung cancer biomarkers.

Authors:  Valerio Del Vescovo; Margherita Grasso; Mattia Barbareschi; Michela A Denti
Journal:  World J Clin Oncol       Date:  2014-10-10

10.  Evaluation of microRNAs as potential biomarkers in circulating HPV-DNA-positive non-small cell lung cancer patients.

Authors:  Yao Wu; Qing Yin; Ya-Ling Zhou; Lei He; Zhi-Qing Zou; Xiao-Yue Dai; Wen Xia
Journal:  Cancer Biol Ther       Date:  2021-02-04       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.